Danone’s Specialized Nutrition division, led by its Oikos Greek yogurt brand, achieved double-digit year-over-year volume growth in high-protein SKUs during fiscal Q4 2025. This acceleration coincided with a 12% penetration of GLP-1 weight-loss medication among U.S. adults, a demographic that Cornell University data shows is increasing spending on yogurt and protein bars by 15–20%. Danone executive commentary highlights that Oikos’s protein-fortified lines now account for 35% of U.S. yogurt unit sales, up from 28% a year earlier.

Market research from Circana indicates food and beverage products carrying high-protein claims command price premiums of up to 12%. Danone has strategically reformulated 60% of its North American dairy SKUs to spotlight per-serving protein levels, enabling the company to lift gross-margin contribution on these items by an average of 180 basis points in 2025. Across its Essential Dairy & Plant-Based division, protein-focused SKUs now generate an estimated €1.2 billion in annual sales, representing 18% of the category’s total revenue.

To meet surging demand for dairy-based protein ingredients, Danone plans to expand capacity at its western U.S. whey-powder facility by 25% in H2 2026, adding two spray-dryers and project-ed to raise annual throughput from 40,000 to 50,000 metric tons. The company has also signed a multi-year supply agreement with a national bakery chain to deliver Danone’s ultra-filtered milk protein concentrate, a move that is expected to generate incremental sales of $45 million over three years. Danone’s in-house R&D team has developed six novel dairy protein isolates, which they say can boost protein content by up to 30% in baked goods without altering texture.